Experimental Alzheimer's drug shows promise, but there are many hurdles still to overcome
The first drug that can slow the rate of decline in Alzheimer's patients has been found. The experimental drug, called lecanemab, is an antibody that targets the toxic clumps of amyloid protein associated with the mind-robbing ...
Dec 2, 2022
0
16